Alkermes plc (ALKS) vs Hims & Hers Health, Inc. (HIMS)
- Alkermes plc ALKS 41.22 +2.79%
- Hims & Hers Health, Inc. HIMS 28.07 −4.46%
Alkermes plc and Hims & Hers Health, Inc. are both Drug Manufacturers Specialty & Generic companies. Alkermes plc and Hims & Hers Health, Inc. are of similar size ($6.9B and $6.7B). Hims & Hers Health, Inc. has negative trailing earnings, so its P/E is not meaningful; Alkermes plc trades at 102×. Hims & Hers Health, Inc. grew revenue faster over the last twelve months: 28.0% against 10.8%. Alkermes plc has the higher net margin (3.97% vs −5.51%) and the higher return on invested capital (2.76% vs −11.4%). Across the 19 metrics below, Alkermes plc leads on 14 and Hims & Hers Health, Inc. on 5.
Valuation
Profitability
| Metric | ALKS | HIMS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 84.56% | 68.43% | 53.94% |
| Operating margin | 7.03% | (5.99%) | 0.00% |
| Net margin | 3.97% | (5.51%) | 0.00% |
| Free cash flow margin | 13.35% | 3.22% | 0.00% |
| Return on equity | 3.85% | (32.03%) | (0.40%) |
| Return on assets | 1.99% | (5.16%) | (3.32%) |
| Return on invested capital | 2.76% | (11.38%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack